莱迪帕斯维尔
索福斯布维尔
医学
共感染
丙型肝炎病毒
肝硬化
不利影响
人类免疫缺陷病毒(HIV)
病毒学
丙型肝炎
内科学
慢性肝炎
病毒
胃肠病学
利巴韦林
作者
Maria Pokorska‐Śpiewak,Anna Dobrzeniecka,Agnieszka Ołdakowska,Magdalena Marczyńska
出处
期刊:Pediatric Infectious Disease Journal
[Ovid Technologies (Wolters Kluwer)]
日期:2021-07-06
卷期号:40 (12): 1087-1089
被引量:2
标识
DOI:10.1097/inf.0000000000003264
摘要
Abstract: We present the efficacy and safety of 12 weeks of therapy with a fixed dose of ledipasvir/sofosbuvir in 2 teenagers with HIV/hepatitis C virus coinfection. Patient 1 presented with compensated cirrhosis, whereas patient 2 had evidence of previous hepatitis B virus infection. Both patients achieved a sustained virologic response 12 weeks after the end of treatment. No serious adverse effects were reported.
科研通智能强力驱动
Strongly Powered by AbleSci AI